ClinicalTrialsFinder
RecruitingNCT03577197

Southeast Netherlands Advanced Metastatic Breast Cancer Registry

Southeast Netherlands Advanced Breast Cancer Registry

Sponsor

Academisch Ziekenhuis Maastricht

Enrollment

7,000 participants

Start Date

Jan 1, 2007

Study Type

OBSERVATIONAL

Conditions

Metastatic Breast CancerAdvanced Breast Cancer

Summary

The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of 2007 in 11 hospitals in the Netherlands. Data on patient, tumor and treatment characteristics are collected retrospectively from electronic medical files by trained registry clerks.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Diagnosed with de novo or recurrent advanced breast cancer since 2007
  • Diagnosed with or treated for advanced breast cancer in one of the participating hospitals
  • Participating hospitals (period of inclusion): Maastricht UMC+ (2007-2025), Zuyderland hospitals Sittard/Heerlen (2007-2025), Amphia Hospital Breda (2013-2025), Catharina Hospital Eindhoven (2007-2025), Elkerliek Hospital Helmond (2010-2025), Maxima Medical Center Veldhoven/Eindhoven (2007-2025), Jeroen Bosch Hospital Den Bosch (2013-2025), Laurentius Hospital Roermond (2007-2025), St. Annaziekenhuis Geldrop (2007-2025), St. Elisabeth Hospital Tilburg (2007-2009), St. Jans Gasthuis Weert (2007-2025), VieCuri Medical Center Venlo/Venray (2013-2025), all in the Netherlands.
  • Hospitals (and periods) were eligible for inclusion if (distant) registration from Maastricht UMC+ was possible.
  • The inclusion period may be prolonged after 2025.

Locations(1)

Multiple hospitals in the Netherlands (see Eligibility)

Maastricht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03577197

Related Trials

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

NCT06157892139 locations

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

NCT066493311 location

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

NCT0699384410 locations

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

NCT059645044 locations

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

NCT0699702921 locations